Ic diariamente, dia 1 a 21 cada 3 semanas x 3 ciclos. Worldwide, it is the second neoplasia in incidence after lung cancer. It has prognosis and treatment defined by the location. Com 1472 pacientes comparando quimioterapia com um unico agente vs combinacao, os autores encontraram. Onate ol, mondragon sr, ruiz rj, cancer gastrico rev.
Gastric cancer is the leading cause of death from malignancy in chile. The cause is multivariate and the risks are well known. Cancer is now a mayor cause of mortality throughout the world and the cancer gastric is first cause of death for neoplasia in colombia. Abstract background in brazil, gastric cancer is the fourth most common malignancy among men and sixth among women. Tratamiento nutricio del paciente con cancer gastrico. Only in developed oriental countries japan, south korea there are screening programs for early detection, that have shown decreased mortality rates from this disease. Pathological response to neoadjuvant 5fu, oxaliplatin, and docetaxel flot versus epirubicin, cisplatin, and 5fu ecf in patients with locally advanced, resectable gastricesophagogastric junction egj cancer. R0 em qualquer n positivo, tumores t3 ou t4, e nas.
1600 706 299 13 705 1010 726 1466 1542 341 353 1413 1460 709 1246 764 1060 843 1454 162 506 1463 423 253 168 1429 430 986 1553 1356 1208 874 770 500 22 488 786 38 131